Raynaud's Phenomenon Treated Effectively With Topical Nitrates

This article originally appeared here.
Share this content:
The results showed a moderate to large treatment effect in both primary and secondary Raynaud's phenomenon.
The results showed a moderate to large treatment effect in both primary and secondary Raynaud's phenomenon.

Topical nitrates may be beneficial for patients with primary and secondary Raynaud's phenomenon, according to a systematic review published in the Journal of the American Academy of Dermatology

For this study, researchers performed a meta-analysis to examine the effects of local topical nitrates in primary and secondary Raynaud's phenomenon with respect to parameters such as digital blood flow and clinical severity. Trials that compared local topical nitrates vs placebo were included in the analysis.

A total of 7 trials involving 346 patients were identified; nitroglycerin ointments were used in 4 trials, MQX-503 in 2 trials, and a compounded nitrite in 1 trial. 

The results showed a moderate to large treatment effect in Raynaud's phenomenon (standardized mean difference [SMD] 0.70; <.0001), with subgroup analysis indicating a larger treatment effect for secondary Raynaud's phenomenon (SMD 0.95; =.008) compared to primary Raynaud's phenomenon (SMD 0.45; =.03).

While the study had its limitations, including the use of multiple topical preparations and different outcome assessments, the authors conclude that "local topical nitrates have significant efficacy in the treatment of both primary and secondary Raynaud's phenomenon."

Reference

Curtiss P, Schwager Z, Cobos G, Lo Sicco K, Franks Jr. AG. A systematic review and meta-analysis of the effects of topical nitrates in the treatment of primary and secondary Raynaud's phenomena [published online February 2, 2018]. J Am Acad Dermatol. doi: 10.1016/j.jaad.2018.01.043

Share this content:
You must be a registered member of Dermatology Advisor to post a comment.

Sign up for Newsletters